Frazier Life Sciences Management L.P. bought a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,184,840 shares of the company’s stock, valued at approximately $15,758,000. Frazier Life Sciences Management L.P. owned 1.93% of Dyne Therapeutics at […]
HashiCorp, Inc. (NASDAQ:HCP – Get Free Report) CMO Marc Holmes sold 13,916 shares of the firm’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $33.74, for a total value of $469,525.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which […]
Ambarella, Inc. (NASDAQ:AMBA – Get Free Report) VP Chi-Hong Ju sold 1,895 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $57.50, for a total transaction of $108,962.50. Following the completion of the sale, the vice president now directly owns 180,252 shares in […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) Director William D. Waddill sold 8,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $35.00, for a total transaction of $280,000.00. Following the completion of the transaction, the director now directly owns 12,000 shares […]
True Wealth Design LLC decreased its position in shares of Corebridge Financial, Inc. (NYSE:CRBG – Free Report) by 8.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,855 shares of the company’s stock after selling 3,435 shares during the quarter. True Wealth […]